HAVCR2 and liver cancer: Studies have shown that tumor-specific cytotoxic T cells in primary liver cancer are accompanied by high expression of inhibitory immune checkpoints such as CTLA4, PD-L1 and TIM3 [22–24], which makes T cells unable to effectively recognize tumor cells and lead to immune escape [25].